News

Allergy Therapeutics shares spike on late-stage data

admin — Thu, 15 May 2008 06:59:58 -0400

Shares of the UK's Allergy Therapeutics surged on the news that its experimental hay fever vaccine--Pollinex Quattro--demonstrated positive results in a crucial Phase III study, which they say was Read more...

Novartis touts mid-stage results for MenB

admin — Thu, 15 May 2008 06:59:57 -0400

Novartis says that a mid-stage study of its MenB vaccine demonstrated broad protection from meningococcal B infections in infants. Researchers tracked positive results starting with three Read more...

Cervarix data demonstrates prolonged protection

admin — Thu, 15 May 2008 06:59:56 -0400

GlaxoSmithKline has released new Cervarix data that demonstrates the vaccine's ability to generate a high and sustained level of antibodies to neutralize the two most prevalent strains of cervical Read more...

Vaccine makers to produce record amount of flu jab

admin — Thu, 15 May 2008 06:59:55 -0400

The five key vaccine makers say they plan to produce a record 143 million doses of flu vaccine for the U.S. market next season, which should be enough to satisfy demand. Manufacturers delivered 140 Read more...

SPOTLIGHT: Intercell to acquire Iomai

admin — Thu, 15 May 2008 06:59:52 -0400

Austria's Intercell is buying Iomai for $189 million in cash and stock. The deal will add Iomai's patch to prevent traveler's diarrhea and an adjuvant for bird flu vaccine that has produced Read more...

ALSO NOTED: Korea blueprints bird flu vaccine factory;HIV researchers vow to pursue vaccine; and much more...

admin — Thu, 15 May 2008 06:59:50 -0400

Vaccine Market South Korea says it will build a bird flu vaccine factory next year. And the country says it will stockpile enough Tamiflu to be able to treat 10 million people in the event of a Read more...

Experts call for long-term immunity tracking studies

admin — Thu, 08 May 2008 06:59:57 -0400

Vaccine experts are pondering just how long vaccines will be able to provide immunity in a world where some diseases are all but eliminated and natural exposure to many common viruses has ended. Read more...

Researchers explore brain cancer vaccine

admin — Thu, 08 May 2008 06:59:56 -0400

Researchers are touting the early results from a study of a new brain cancer vaccine that combines protein antigens extracted from a patient's tumor and matches them with white cells also drawn from Read more...

VaxGen sells anthrax vaccine to its old rival

admin — Thu, 08 May 2008 06:59:55 -0400

Reduced to a skeleton crew and a bleak outlook, South San Francisco-based VaxGen sold its experimental anthrax vaccine to its former chief rival, Emergent BioSolutions, for $2 million down and up to Read more...

SPOTLIGHT: Covance wins CRO award

admin — Thu, 08 May 2008 06:59:52 -0400

Covance, the inaugural sponsor of FierceVaccines, was recognized as the Best CRO at the 2008 World Vaccine Congress. The award recognizes for providing services that support vaccine development. Read more...

ALSO NOTED: Vaccine benefits studied; Menveo wins head-to-head study;and much more...

admin — Thu, 08 May 2008 06:59:50 -0400

Vaccine Market Harvard economist Dr. David E. Bloom has studied the economic impact of an effective national program for vaccinations, outlining how better health improves a person's wealth. Read more...

FDA orders Merck to fix vaccine plant problems

admin — Thu, 01 May 2008 06:59:57 -0400

The FDA has given Merck 15 days to decide how to fix Read more...

Discovery offers shortcut to custom flu vaccines

admin — Thu, 01 May 2008 06:59:56 -0400

A team of researchers at Emory University and the Oklahoma Medical Research Foundation has found a way to radically upend the way new vaccines are developed to fight a pandemic. Just days after a Read more...

Many infants don't get vaccinations on time

admin — Thu, 01 May 2008 06:59:55 -0400

A large group of American parents are having a tough time keeping up with their kids' vaccination schedules. More than a quarter of all children are under-vaccinated, with missed doses accounting Read more...

SPOTLIGHT: Researchers probe attitudes to HPV vaccine

admin — Thu, 01 May 2008 06:59:52 -0400

Researchers have found that the younger a girl is, the less likely it is that her mother is prepared to arrange a vaccination against HPV. But the researchers note that the girls would benefit most Read more...